HIV Integration Targeting: A Pathway Involving Transportin-3 and the Nuclear Pore Protein RanBP2
Author Information
Author(s): Karen E. Ocwieja, Troy L. Brady, Ronen Keshet, Alyssa Huegel, Shoshannah L. Roth, Torsten Schaller, Leo C. James, Greg J. Towers, John A. T. Young, Sumit K. Chanda, Renate König, Nirav Malani, Charles C. Berry, Frederic D. Bushman
Primary Institution: Department of Microbiology, University of Pennsylvania School of Medicine
Hypothesis
Does the depletion of Transportin-3 and RanBP2 affect HIV integration targeting?
Conclusion
Depletion of Transportin-3 and RanBP2 alters HIV integration frequency and targeting to gene-dense regions.
Supporting Evidence
- Depletion of Transportin-3 and RanBP2 altered integration targeting for HIV.
- Knockdowns reduced HIV integration frequency in gene-dense regions.
- MLV integration was not affected by the Transportin-3 knockdown.
- Integration site distributions were significantly altered in knockdown cells.
- Transportin-3 and RanBP2 are required for HIV to achieve its normal pattern of integration sites.
Takeaway
This study shows that certain proteins help HIV find the best spots to insert itself into our DNA, which is important for the virus to replicate.
Methodology
The study used RNA interference to knock down Transportin-3 and RanBP2, followed by integration site analysis using DNA bar coding and pyrosequencing.
Potential Biases
Potential off-target effects of siRNA treatments were not fully ruled out.
Limitations
The effects of some gene knockdowns were complicated by cell toxicity, making interpretations less certain.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website